TriMas Co. (NASDAQ:TRS - Free Report) - Research analysts at Zacks Research raised their Q4 2024 EPS estimates for TriMas in a report released on Monday, January 27th. Zacks Research analyst M. Das now expects that the industrial products company will post earnings per share of $0.48 for the quarter, up from their previous forecast of $0.47. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas' Q3 2025 earnings at $0.59 EPS, Q4 2026 earnings at $0.50 EPS and FY2026 earnings at $2.10 EPS.
A number of other analysts have also issued reports on the stock. BWS Financial reiterated a "buy" rating and set a $40.00 price objective on shares of TriMas in a research note on Thursday, January 23rd. StockNews.com upgraded TriMas from a "sell" rating to a "hold" rating in a research report on Wednesday, November 13th.
Get Our Latest Stock Analysis on TRS
TriMas Trading Down 0.7 %
TRS stock traded down $0.18 on Wednesday, hitting $24.49. 212,647 shares of the company were exchanged, compared to its average volume of 237,247. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The stock has a market capitalization of $993.61 million, a price-to-earnings ratio of 38.27 and a beta of 0.67. The business's fifty day moving average is $25.03 and its two-hundred day moving average is $25.44. TriMas has a twelve month low of $22.24 and a twelve month high of $28.51.
TriMas (NASDAQ:TRS - Get Free Report) last issued its earnings results on Monday, November 4th. The industrial products company reported $0.43 EPS for the quarter, missing the consensus estimate of $0.57 by ($0.14). The company had revenue of $229.36 million for the quarter, compared to analysts' expectations of $239.33 million. TriMas had a return on equity of 9.21% and a net margin of 2.93%. TriMas's revenue for the quarter was down 2.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.57 earnings per share.
Institutional Trading of TriMas
Institutional investors have recently bought and sold shares of the stock. Western Standard LLC raised its stake in TriMas by 86.6% during the 3rd quarter. Western Standard LLC now owns 169,069 shares of the industrial products company's stock worth $4,316,000 after buying an additional 78,450 shares during the period. Impax Asset Management Group plc increased its position in shares of TriMas by 216.4% during the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company's stock worth $10,467,000 after purchasing an additional 280,431 shares during the last quarter. Barclays PLC grew its position in shares of TriMas by 341.3% in the 3rd quarter. Barclays PLC now owns 68,792 shares of the industrial products company's stock valued at $1,755,000 after acquiring an additional 53,203 shares during the period. Allspring Global Investments Holdings LLC lifted its position in shares of TriMas by 1.7% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,145,236 shares of the industrial products company's stock valued at $80,298,000 after buying an additional 51,701 shares during the last quarter. Finally, Jane Street Group LLC boosted its position in TriMas by 74.4% during the third quarter. Jane Street Group LLC now owns 82,621 shares of the industrial products company's stock worth $2,109,000 after purchasing an additional 35,258 shares during the period. Institutional investors and hedge funds own 99.42% of the company's stock.
About TriMas
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Recommended Stories
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.